Daklinza Interactions
There are 255 drugs known to interact with Daklinza (daclatasvir), along with 1 disease interaction. Of the total drug interactions, 60 are major, 190 are moderate, and 5 are minor.
- View all 255 medications that may interact with Daklinza
- View Daklinza disease interactions (1)
Most frequently checked interactions
View interaction reports for Daklinza (daclatasvir) and the medicines listed below.
- Advate (antihemophilic factor)
- Aldactone (spironolactone)
- Aldurazyme (laronidase)
- amitriptyline
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- cannabis
- Cerdelga (eliglustat)
- Corifact (factor XIII)
- Elaprase (idursulfase)
- Enbrel (etanercept)
- Exjade (deferasirox)
- Feiba (anti-inhibitor coagulant complex)
- Gleevec (imatinib)
- Harvoni (ledipasvir / sofosbuvir)
- Incivek (telaprevir)
- lactulose
- Lamictal (lamotrigine)
- Lasix (furosemide)
- Lucentis (ranibizumab ophthalmic)
- Marplan (isocarboxazid)
- Moderiba (ribavirin)
- Neoral (cyclosporine)
- NovoSeven RT (coagulation factor viia)
- Placidyl (ethchlorvynol)
- Soliris (eculizumab)
- Sovaldi (sofosbuvir)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
Daklinza disease interactions
There is 1 disease interaction with Daklinza (daclatasvir) which include:
More about Daklinza (daclatasvir)
- Daklinza consumer information
- Compare alternatives
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NS5A inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.